Atlas Trials

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

Clinical trial NCT02926898 · COMPLETED

Trial details

NCT number
NCT02926898
Sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dravet Syndrome
Start date
2017-01-27
Primary completion
2018-06-05
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.